GK2-24901-83473
3 vaccinations
1 coded response
8 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 981 / WA
- Registered
- 2021-12-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-02
Dose 1 — Moderna
-
2021-04-30
Dose 2 — Moderna
-
2021-12-10
Registered in v-safe
-
2021-12-10
Dose 3 — Pfizer-BioNTech
-
2021-12-10
Survey response — day 0, dose 3MedDRA: Injection site pain — Feeling: Fair · Fatigue or tirednessFree text: Injection site is soreMedDRA releases: 2024-11 · check-in free text available
-
2021-12-11
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend schoolAdult check-in
- 2021-12-12
- 2021-12-15
- 2021-12-16
- 2021-12-17
- 2021-12-24
- 2021-12-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-02 | Moderna | No |
| 2 | 2021-04-30 | Moderna | No |
| 3 | 2021-12-10 | Pfizer-BioNTech | No |
Free text
Release 10 — day 0, dose 3
Systemic reaction (other): Injection site is sore
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Injection site pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release